NAV

Influenza B virus B/Wisconsin/1/2010 recombinant hemagglutinin antigen

This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Influenza B virus B/Wisconsin/1/2010 recombinant hemagglutinin antigen
DrugBank Accession Number
DB10775
Background

seasonally-specific组件的流感vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". This defence includes the production of humoral immunity through the development of antibodies (through memory B cells) and of cell-mediated immunity through the production of T-lymphocytes. Upon re-exposure to infectious influenza virus, the immune system is prepared to identify and destroy the virus as there are circulating antibodies that recognize that particular component of the virus that it was previously exposed to.

There are two basic types of vaccines available: inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde 3. Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques. Live vaccines maintain their replicative ability.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Recombinant
Synonyms
  • Influenza B virus vaccine, B-Wisconsin-1-2010-like virus

Ph值armacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Ph值armacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Ph值armacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image
Flublok Influenza B virus B/Wisconsin/1/2010 recombinant hemagglutinin antigen(45 ug/0.5mL)+Influenza A virus A/California/7/2009 (H1N1) recombinant hemagglutinin antigen(45 ug/0.5mL)+Influenza A virus A/Victoria/361/2011 (H3N2) recombinant hemagglutinin antigen(45 ug/0.5mL) Injection, solution Intramuscular Protein Sciences Corporation 2013-02-01 2013-06-30 US flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
N9C76986U2
CAS number
Not Available

References

一般引用
Not Available
RxNav
1303855

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Ph值ase Status Purpose Conditions Count
4 Active Not Recruiting Prevention Coronavirus Disease 2019 (COVID‑19)/Influenza, Human 1
4 Active Not Recruiting Prevention Flu caused by Influenza/Influenza, Human/Influenza-like Illness 1
4 Completed Basic Science Flu caused by Influenza 2
4 Completed Basic Science Flu Vaccine 1
4 Completed Prevention Flu caused by Influenza 1
4 Completed Supportive Care Acute Myeloid Leukemia/Myelodysplastic Syndrome 1
3 Completed Prevention Flu caused by Influenza 5
2, 3 Completed Prevention Flu caused by Influenza 1
1 Completed Treatment Head And Neck Cancer/Squamous Cell Carcinoma of the Head and Neck (SCCHN) 1
1, 2 Completed Prevention Flu caused by Influenza 1

Ph值armacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Form Route Strength
Injection, solution Intramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53